These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 12060631)

  • 1. Prognostic significance of preoperative molecular serum analysis in renal cancer.
    Gonzalgo ML; Eisenberger CF; Lee SM; Trock BJ; Marshall FF; Hortopan S; Sidransky D; Schoenberg MP
    Clin Cancer Res; 2002 Jun; 8(6):1878-81. PubMed ID: 12060631
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concentration and microsatellite status of plasma DNA for monitoring patients with renal carcinoma.
    Perego RA; Corizzato M; Brambilla P; Ferrero S; Bianchi C; Fasoli E; Signorini S; Torsello B; Invernizzi L; Bombelli S; Angeloni V; Pitto M; Battaglia C; Proserpio V; Magni F; Galasso G; Mocarelli P
    Eur J Cancer; 2008 May; 44(7):1039-47. PubMed ID: 18397824
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular serological diagnosis in transitional cell bladder cancer.
    von Knobloch R; Brandt H; Hofmann R
    Ann N Y Acad Sci; 2004 Jun; 1022():70-5. PubMed ID: 15251942
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between recurrence of sporadic colorectal cancer, high level of microsatellite instability, and loss of heterozygosity at chromosome 18q.
    Sarli L; Bottarelli L; Bader G; Iusco D; Pizzi S; Costi R; D'Adda T; Bertolani M; Roncoroni L; Bordi C
    Dis Colon Rectum; 2004 Sep; 47(9):1467-82. PubMed ID: 15486743
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients.
    Taback B; Fujiwara Y; Wang HJ; Foshag LJ; Morton DL; Hoon DS
    Cancer Res; 2001 Aug; 61(15):5723-6. PubMed ID: 11479206
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Squamous cell carcinoma of the esophagus can be detected by microsatellite analysis in tumor and serum.
    Eisenberger CF; Knoefel WT; Peiper M; Merkert P; Yekebas EF; Scheunemann P; Steffani K; Stoecklein NH; Hosch SB; Izbicki JR
    Clin Cancer Res; 2003 Sep; 9(11):4178-83. PubMed ID: 14519643
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor associated trypsin inhibitor as a prognostic factor in renal cell carcinoma.
    Paju A; Jacobsen J; Rasmuson T; Stenman UH; Ljungberg B
    J Urol; 2001 Mar; 165(3):959-62. PubMed ID: 11176522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nephron-sparing surgery for renal cell carcinoma in the solitary kidney.
    Berdjis N; Hakenberg OW; Novotny V; Manseck A; Oehlschläger S; Wirth MP
    Scand J Urol Nephrol; 2007; 41(1):10-3. PubMed ID: 17366096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Wnt antagonist family genes as biomarkers for diagnosis, staging, and prognosis of renal cell carcinoma using tumor and serum DNA.
    Urakami S; Shiina H; Enokida H; Hirata H; Kawamoto K; Kawakami T; Kikuno N; Tanaka Y; Majid S; Nakagawa M; Igawa M; Dahiya R
    Clin Cancer Res; 2006 Dec; 12(23):6989-97. PubMed ID: 17145819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laparoscopic and open partial nephrectomy: a matched-pair comparison of 200 patients.
    Marszalek M; Meixl H; Polajnar M; Rauchenwald M; Jeschke K; Madersbacher S
    Eur Urol; 2009 May; 55(5):1171-8. PubMed ID: 19232819
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small renal tumors: correlation of clinical and pathological features with tumor size.
    Pahernik S; Ziegler S; Roos F; Melchior SW; Thüroff JW
    J Urol; 2007 Aug; 178(2):414-7; discussion 416-7. PubMed ID: 17561161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsatellite analysis of serum DNA in patients with oral squamous cell carcinoma.
    Kakimoto Y; Yamamoto N; Shibahara T
    Oncol Rep; 2008 Nov; 20(5):1195-200. PubMed ID: 18949421
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased preoperative serum C-reactive protein level predicts a poor prognosis in patients with localized renal cell carcinoma.
    Komai Y; Saito K; Sakai K; Morimoto S
    BJU Int; 2007 Jan; 99(1):77-80. PubMed ID: 16956357
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Microsatellite analysis of plasma DNA from patients with clear cell renal carcinoma.
    Goessl C; Heicappell R; Münker R; Anker P; Stroun M; Krause H; Müller M; Miller K
    Cancer Res; 1998 Oct; 58(20):4728-32. PubMed ID: 9788629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prediction of postoperative renal function by preoperative serum creatinine level and three-dimensional diagnostic image reconstruction in patients with renal cell carcinoma.
    Tanaka N; Fujimoto K; Tani M; Yoshii M; Yoshida K; Hirao Y; Ozono S
    Urology; 2004 Nov; 64(5):904-8. PubMed ID: 15533475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
    Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK
    J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microsatellite analysis of voided-urine samples for surveillance of low-grade non-muscle-invasive urothelial carcinoma: feasibility and clinical utility in a prospective multicenter study (Cost-Effectiveness of Follow-Up of Urinary Bladder Cancer trial [CEFUB]).
    van der Aa MN; Zwarthoff EC; Steyerberg EW; Boogaard MW; Nijsen Y; van der Keur KA; van Exsel AJ; Kirkels WJ; Bangma C; van der Kwast TH
    Eur Urol; 2009 Mar; 55(3):659-67. PubMed ID: 18501499
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic impact of postoperative C-reactive protein level in patients with metastatic renal cell carcinoma undergoing cytoreductive nephrectomy.
    Tatokoro M; Saito K; Iimura Y; Fujii Y; Kawakami S; Kihara K
    J Urol; 2008 Aug; 180(2):515-9. PubMed ID: 18550105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.